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ABSTRACT
A great deal of biomedical research focuses on new biotechnologies such as gene editing, stem cell biology,
and reproductive medicine, which have created a scientific revolution. While the potential medical benefits
of this research may be far-reaching, ethical issues related to non-medical applications of these technologies
are demanding. We analyze, from a Jewish legal perspective, some of the ethical conundrums that society
faces in pushing the outer limits in researching these new biotechnologies.
KEY WORDS: Bioethics, gene editing, medical ethics

INTRODUCTION
Society is in the midst of a technological revolution,
especially in reproductive medicine and molecular
genetics, areas that hold the promise of improving
human health in unimaginable ways. In 2017, for
example, scientists have applied gene-editing
(clustered regularly interspaced short palindromic
repeats, referred to as CRISPR) technology to correct
the genetic cause of a fetal heart disease, hypertrophic cardiomyopathy, and a common blood disease,
β-thalassemia.1,2 The use of this technology in utero
can enable babies to be born without these serious
and sometimes fatal diseases. Another example of
potentially life-saving advances in biotechnology and

organ transplantation is using human stem cells to
create chimeric pigs that develop human organs.3–5
These scientific achievements are both exciting
and ethically challenging.6,7 The excitement is the
hope that gene-editing technology can be useful in
correcting some of the over 10,000 mutations that
can cause human disease. Creating chimeric humanpigs offers a unique opportunity for people whose
own livers, kidneys, or hearts are irreversibly failing,
to safely receive organs donated from animals.
The ethical concerns regarding these biotechnologies are many. Will society limit their use to
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curing disease, or will also people begin to use technology for non-medical purposes? Creating “designer
babies” such as those with particular facial structures or enhanced intelligence is one such concern
that has been problematic since the days of the
original 1967 Star Trek episode, “Space Seed” (which
inspired the film Star Trek II: The Wrath of Khan).
Another group of science fiction writers who penned
Planet of the Apes note that there is also a fear of
creating animals with reconstituted human brains or
human speech and of placing people at risk of
unknown side effects. Moreover, some people
believe that such technologies are unethical because
they enable human beings to “play God” by tampering with the holy genetic grail or interfering with the
normal evolution of species.
BALANCING SCIENTIFIC INNOVATION
WITH ETHICAL CONCERNS
How should society balance the innate human desire
to innovate new technologies with the fear that their
applications may violate ethical norms? While these
debates are ongoing, current United States government guidelines ban the use of federal funds to
modify embryos using technologies such as CRISPR.
If science has the capacity to save lives through such
technology, are we ethically justified in not moving
this forward?
When viewed through the Jewish lens of the
Bible (written law) and the Talmud (oral law), there
is precedent for legal and moral deliberations of this
kind. Jewish philosophy and law have debated similar issues over the past two thousand years and offer
meaningful guidelines that address the question of
balancing scientific discovery with the fear of
unethical applications. Great rabbinical thinkers
from Nachmanides (thirteenth century) to Rabbi
Joseph Soloveitchik (twentieth century) stated that
God created an incomplete world in which human
beings must utilize their creative capacities to
complete the creation process. In other words, God
directed human beings to partner with Him to finish
the creation process.8–10
PLAYING GOD—MORAL IMPERATIVE?
The lessons from these discussions relate most profoundly to current times. We propose that a Divine
directive is for human society to embrace science by
actively supporting the research of natural law and
applying it wisely. This Divine directive represents a
universal directive for all humanity. Clearly, the Bible
Rambam Maimonides Medical Journal

and Talmud understood that human inhabitation of
this world requires scientific research that encompasses biology, chemistry, and physics to enable human beings to live in an environmentally, biologically, and medically healthy society. Thus, the concept
of human beings “playing God” can be viewed as an
ethical principle not an immoral activity.
Judaism recognizes that scientific research begins
by understanding basic principles underlying biological and cellular processes through observation of
the wide variety of biological life. Biological precedent is an important guideline in both scientific
discovery and applications. In fact, scientists incorporate this philosophical approach today. Gene
editing is one example of a scientific discovery that
originated from basic research in virology that
showed how a simple bacterium can protect itself
from an invading virus.11
Jewish law also presents a profound directive
from the classical moral objective that one is obligated to “refrain from doing bad and do good.” 12,13
Judaism believes that the ideal objective is to transform the evil into goodness. The Talmud states that
the answers to curing human diseases lie within the
laws of nature because God created the cures for all
diseases even before He created disease pathology.14
There is no better example of this concept than what
we are currently witnessing in the excitement
surrounding immunotherapy and cancer.15 Understanding why our immune system fails to fight
tumors has enabled scientists to re-educate our T
cells to fight and destroy lethal cancers.
A PATH FOR ETHICAL ANALYSIS
The challenge is how to apply scientific research in
practice in a morally acceptable manner. The Supreme Court of Jewish Law would always address
religious legal questions at two levels in a manner
similar to how the US supreme court deals with difficult cases.16,17 The first level was a general, theoretical legal analysis of the history of law and how the
populace practiced the parameters of a law. The
second level was a practical and particular approach,
examining each situation according to the individual
circumstances and developing the response according to the specific details and characteristics of that
situation. Indeed, Jewish law places a much greater
emphasis on the latter principle—each case must be
evaluated individually on its merits and details.
We believe there is much merit in this type of
analysis regarding the new biotechnologies being
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developed. First, we must ethically analyze the various procedures underlying the biotechnology. Does
it involve harming animals? Does it violate basic principles of bioethics? Then, we should address these
principles as they apply to a particular situation and
recognize that all technologies, while morally neutral,
have the potential to do both good and/or to do harm.
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Translational biotechnology, in order to develop
new therapies for disease, is the ultimate objective
of science and is part of the Divine directive for
human beings to partner with God. However, society
must be careful of the outer limits of technology that
may be unethical. Do the ethical outer limits of
technology include non-medical procedures such as
sex-selection, cosmetic changes (hair or eye color,
height), or tampering with biological species to create new species, such as animals with human neurons, or monkeys with human genes that regulate
human speech?
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The general rule in Judaism is that gene editing
for non-medical applications is ethically wrong and
should not be routinely acceptable. In the case of
gene-editing a human embryo, we believe it is moral
and ethical to genetically edit not only an embryo
carrying lethal genes (e.g. Tay–Sachs) but also in
cases where the child would be born and burdened
with serious health issues (e.g. cystic fibrosis).
The Torah states that its laws are created for
people to live by, and so we should support medical
and technological advances that promote the saving
of lives. We should advocate that society commit significant government and private funding to basic
research. This also includes supporting research for
creative procedures that protect the weaker segments
of the population in order to provide fair allocation
of treatments. We advocate continuing to push the
limits of scientific research, but at the same time, we
must not allow the unethical, non-medical applications. In the realm of new biotechnology, the goal of
partnering with God to save lives should be
paramount. It is not what you can do but what you
should do.
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